Innovent Biologics's total assets for Q2 2022 were ¥16.16B, a decrease of -0.52% from the previous quarter. IVBXF total liabilities were ¥― for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.